GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas and CARESCAPE ONE are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service.

“As patient acuity and disease trends change rapidly, adaptability in the hospital setting is becoming more important. We look for ways to improve the care experience by delivering quality clinical measurements where and when they are needed, giving care providers the information they need to make the best possible clinical decisions,” Dr. Roland Schrewe, head of PICU, University of Frankfurt. “GE HealthCare’s CARESCAPE Canvas provides a precise, standardized and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable.”

CARESCAPE Canvas is a FlexAcutity solution equipped with smart parameter technology that can be used for patients at all levels of acuity. This monitoring platform offers flexibility, standardization and ease of use by leveraging micromodules that connect with standardized medical USB technology — simply adding or disconnecting cables equipped for various configurations enables more efficient care based on patient care needs. It is also equipped with flexible, easy to configure software and interchangeable frames for advanced parameters, enable monitoring devices to be quickly redeployed across the hospital enterprise as needed.

RELATED: FDA Approval for BIOTRONIK’s Prospera™ Spinal Cord Stimulation System

“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, general manager, monitoring solutions, GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. CARESCAPE Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”

The CARESCAPE Canvas bedside monitor was developed and tested with the rest of GE HealthCare’s ecosystem, not only with the current devices available, but also with prior versions that are used across the 100 million patients monitored by GE HealthCare devices each year. This backward compatibility allows healthcare systems to upgrade to the latest capabilities at their pace. CARESCAPE Canvas was also developed with sustainability in mind, with a 53% reduction in packaging volume1, 48% reduction in packaging weight compared to previous generation monitor1, and a 25% reduction in energy consumption compared to previous models2. In addition, CARESCAPE Canvas monitors made at GE HealthCare’s Helsinki site are manufactured by using 100% renewable wind electricity3.

ABOUT GE HEALTHCARE TECHNOLOGIES INC.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 50,000 employees working to create a world where healthcare has no limits.